Literature DB >> 18492729

Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease.

M Hoefer1, S C Allison, G F Schauer, J M Neuhaus, J Hall, J N Dang, M W Weiner, B L Miller, H J Rosen.   

Abstract

Emotional blunting and abnormal processing of rewards and punishments represent early features of frontotemporal lobar degeneration (FTLD). Better understanding of the physiological underpinnings of these emotional changes can be facilitated by the use of classical psychology approaches. Fear conditioning (FC) is an extensively used paradigm for studying emotional processing that has rarely been applied to the study of dementia. We studied FC in controls (n = 25), Alzheimer's disease (n = 25) and FTLD (n = 25). A neutral stimulus (coloured square on a computer screen) was repeatedly paired with a 1 s burst of 100 db white noise. Change in skin conductance response to the neutral stimulus was used to measure conditioning. Physiological-anatomical correlations were examined using voxel-based morphometry (VBM). Both patient groups showed impaired acquisition of conditioned responses. However, the basis for this deficit appeared to differ between groups. In Alzheimer's disease, impaired FC occurred despite normal electrodermal responses to the aversive stimulus. In contrast, FTLD patients showed reduced skin conductance responses to the aversive stimulus, which contributed significantly to their FC deficit. VBM identified correlations with physiological reactivity in the amygdala, anterior cingulate cortex, orbitofrontal cortex and insula. These data indicate that Alzheimer's disease and FTLD both show abnormalities in emotional learning, but they suggest that in FTLD this is associated with a deficit in basic electrodermal response to aversive stimuli, consistent with the emotional blunting described with this disorder. Deficits in responses to aversive stimuli could contribute to both the behavioural and cognitive features of FTLD and Alzheimer's disease. Further study of FC in humans and animal models of dementia could provide a valuable window into these symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18492729      PMCID: PMC2544622          DOI: 10.1093/brain/awn082

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  65 in total

1.  Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans.

Authors:  Christian Grillon; Jeremy Cordova; Charles Andrew Morgan; Dennis S Charney; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

2.  Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning.

Authors:  Catherine M Brignell; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

3.  Detecting activations in PET and fMRI: levels of inference and power.

Authors:  K J Friston; A Holmes; J B Poline; C J Price; C D Frith
Journal:  Neuroimage       Date:  1996-12       Impact factor: 6.556

4.  Frontotemporal dementia as a neural system disease.

Authors:  Marina Boccardi; Francesca Sabattoli; Mikko P Laakso; Cristina Testa; Roberta Rossi; Alberto Beltramello; Hilkka Soininen; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2005-01       Impact factor: 4.673

5.  Human forebrain activation by visceral stimuli.

Authors:  A B King; R S Menon; V Hachinski; D F Cechetto
Journal:  J Comp Neurol       Date:  1999-11-01       Impact factor: 3.215

6.  Neuroanatomical correlates of behavioural disorders in dementia.

Authors:  Howard J Rosen; Stephen C Allison; Guido F Schauer; Maria Luisa Gorno-Tempini; Michael W Weiner; Bruce L Miller
Journal:  Brain       Date:  2005-09-29       Impact factor: 13.501

7.  Neuropathologic substrate of mild cognitive impairment.

Authors:  William R Markesbery; Frederick A Schmitt; Richard J Kryscio; Daron G Davis; Charles D Smith; David R Wekstein
Journal:  Arch Neurol       Date:  2006-01

8.  Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making.

Authors:  A Bechara; H Damasio; A R Damasio; G P Lee
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

9.  Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory.

Authors:  Mohammed R Milad; Brian T Quinn; Roger K Pitman; Scott P Orr; Bruce Fischl; Scott L Rauch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-15       Impact factor: 11.205

10.  Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease.

Authors:  Michael Basso; John Yang; Lauren Warren; Martha G MacAvoy; Pradeep Varma; Richard A Bronen; Christopher H van Dyck
Journal:  Psychiatry Res       Date:  2006-03-09       Impact factor: 3.222

View more
  46 in total

1.  Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies.

Authors:  Julio A Alfieri; Natalia S Pino; Lionel M Igaz
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Mutual gaze in Alzheimer's disease, frontotemporal and semantic dementia couples.

Authors:  Virginia E Sturm; Megan E McCarthy; Ira Yun; Anita Madan; Joyce W Yuan; Sarah R Holley; Elizabeth A Ascher; Adam L Boxer; Bruce L Miller; Robert W Levenson
Journal:  Soc Cogn Affect Neurosci       Date:  2010-06-29       Impact factor: 3.436

3.  α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

Authors:  Volodymyr I Pidoplichko; Eric M Prager; Vassiliki Aroniadou-Anderjaska; Maria F M Braga
Journal:  J Neurophysiol       Date:  2013-09-04       Impact factor: 2.714

Review 4.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

Review 5.  Reward processing in neurodegenerative disease.

Authors:  David C Perry; Joel H Kramer
Journal:  Neurocase       Date:  2014-01-13       Impact factor: 0.881

6.  Facial expressiveness and physiological arousal in frontotemporal dementia: Phenotypic clinical profiles and neural correlates.

Authors:  Fiona Kumfor; Jessica L Hazelton; Jacqueline A Rushby; John R Hodges; Olivier Piguet
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

7.  Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice.

Authors:  Miroslav N Nenov; Fernanda Laezza; Sigmund J Haidacher; Yingxin Zhao; Rovshan G Sadygov; Jonathan M Starkey; Heidi Spratt; Bruce A Luxon; Kelly T Dineley; Larry Denner
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

8.  MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration.

Authors:  Jennifer L Whitwell; Clifford R Jack; Matthew L Senjem; Joseph E Parisi; Bradley F Boeve; David S Knopman; Dennis W Dickson; Ronald C Petersen; Keith A Josephs
Journal:  Neurodegener Dis       Date:  2009-03-19       Impact factor: 2.977

Review 9.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

Review 10.  Mouse models of frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.